Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
(Human metapneumovirus + parainfluenza virus + respiratory syncytial virus) vaccine by Sanofi for Human Metapneumovirus Infections: Likelihood of Approval
(Human metapneumovirus + parainfluenza virus + respiratory syncytial virus) vaccine is under clinical development by Sanofi and currently in Phase...
Data Insights
(Human metapneumovirus + parainfluenza virus + respiratory syncytial virus) vaccine by Sanofi for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
(Human metapneumovirus + parainfluenza virus + respiratory syncytial virus) vaccine is under clinical development by Sanofi and currently in Phase...